Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Generic smoking cessation aid receives tentative FDA approval

Jan. 13, 1999

Novel cocaine analogues with promise in the treatment of cocaine addiction or overdose

Jan. 8, 1999

FDA approves OTC status for Elan's nicotine patch

Jan. 7, 1999

Selective inhibitor of neuronal dopamine transporter developed by U.S. university team

Jan. 4, 1999

Lilly develops novel 5-HT1A/5-HT1D antagonists for smoking cessation and CNS disorders

Dec. 23, 1998

SB launches smoking cessation line in European markets

Dec. 1, 1998

U.S. university researchers claim cocaine analogues for drug addiction, PD and depression

Nov. 27, 1998

Nicotinic acetylcholine receptor ligands for nicotine addiction and CNS disorders

Nov. 11, 1998

Apotex conducting early studies on oral chelating agents

Oct. 27, 1998

Animal studies provide further support for the role of dopaminergic systems in alcoholism

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...